Clinical Trials Browser

INDUSTRY × Head and Neck Neoplasms × cixutumumab × Clear all

NCT00617734 2018-04-17

Study of IMC-A12, Alone or in Combination With Cetuximab, in Participants With Recurrent or Metastatic Squamous Cell Carcinoma (MSCC) of the Head and Neck

Phase 2 Completed

97 enrolled 18 charts

Head and Neck Neoplasms